Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-09-03ATHA3Form 3 Filing for LeonaBio, Inc. - Ownership ChangeMEDIUM
This filing reports a change in beneficial ownership for David J. Portman, with LeonaBio, Inc. (LONA). Mr. Portman, identified by CIK 0002126186, is filing as a 10% owner. The filing specifically addresses a warrant held by Sermonix Pharmaceuticals, Inc., where Mr. Portman serves as CEO. While Mr. Portman has voting co...
Nano CapBiotechnology
2026-09-03CORT3Corcept Therapeutics Form 3: Initial Beneficial Ownership Report for New President, Oncology Roberto VieiraMEDIUM
On September 3, 2026, Corcept Therapeutics Incorporated filed a Form 3 initial statement of beneficial ownership on behalf of Roberto Vieira, who serves as President, Oncology. The filing reports his direct beneficial ownership of 4,068 shares of common stock, which includes shares underlying unvested restricted stock ...
Large CapBiotechnology
2026-09-02ACRV3Power of Attorney for SEC Filings
This filing details a Power of Attorney granted by Michaela Levin, Chief Business Officer of Acrivon Therapeutics, Inc., to designated individuals. The attorneys-in-fact are authorized to execute and submit SEC filings, including Forms 3, 4, 5, and 144, on behalf of Ms. Levin. This includes preparing, executing, and fi...
Micro CapBiotechnology
2026-09-02IVVD3Power of Attorney for Section 16 and Rule 144 Reporting ObligationsMEDIUM
This filing details a Power of Attorney granted by Ian Sheffield, an officer and director of Invivyd, Inc., to a group of individuals including William E. Duke, Jill Andersen, Katherine Fisher, Kiernan Decker, Stephen Nicolai, Amanda Brown, and Tyler Glass. This power of attorney authorizes the appointed individuals to...
Micro CapBiotechnology